gemcitabine has been researched along with Cachexia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, M; Hisano, T; Lee, L; Miki, M; Sugimoto, R | 1 |
| Fujishiro, M; Hakuta, R; Hamada, T; Ishigaki, K; Kanai, S; Nakai, Y; Oyama, H; Saito, K; Saito, T; Sato, T; Suzuki, T; Suzuki, Y; Takahara, N; Tateishi, R | 1 |
| Baar, K; Chen, S; Cortez, NE; Crone, R; Gomes, AV; Hong, BV; Mackenzie, GG; Pathak, S; Rodriguez Lanzi, C; Sule, R; Wang, F | 1 |
| Abe, K; Gocho, T; Haruki, K; Onda, S; Sakamoto, T; Takano, Y; Uwagawa, T; Yanaga, K | 1 |
| Amundsen, T; Grønberg, BH; Helbostad, JL; Hjelde, H; Kaasa, S; Stene, GB; Sørhaug, S | 1 |
| Jia, L; Jiang, SM; Wu, JH | 1 |
| Arseneau, J; Caprioni, F; Corringham, R; De Boer, C; DeWitte, M; Friess, H; Lu, JD; Malfertheiner, P; Mantovani, G; Prabhakar, U; Qi, M; Richel, D; Ritch, P; Robinson, D; Van Cutsem, E; Von Hoff, D; Wiedenmann, B; Zhong, B | 1 |
1 review(s) available for gemcitabine and Cachexia
| Article | Year |
|---|---|
Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse survival after second-line therapy of advanced pancreatic cancer.
Topics: Adipose Tissue; Albumins; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cachexia; Deoxycytidine; Gemcitabine; Humans; Muscle, Skeletal; Paclitaxel; Pancreatic Neoplasms | 2022 |
3 trial(s) available for gemcitabine and Cachexia
| Article | Year |
|---|---|
Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy.
Topics: Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cachexia; Camptothecin; Combined Modality Therapy; Deoxycytidine; Dietary Supplements; Drug Combinations; Fatty Acids, Omega-3; Female; Fluorouracil; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Nutritional Support; Organoplatinum Compounds; Oxonic Acid; Paclitaxel; Pancreatic Neoplasms; Pyridines; Tegafur | 2018 |
Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Drug Dosage Calculations; Female; Gemcitabine; Humans; Lumbosacral Region; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Palliative Care; Pilot Projects; Radiography; Sarcopenia; Sex Factors; Vinblastine; Vinorelbine | 2015 |
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Infliximab; Liver Neoplasms; Male; Pancreatic Neoplasms; Placebos; Prognosis; Survival Rate | 2008 |
3 other study(ies) available for gemcitabine and Cachexia
| Article | Year |
|---|---|
Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study.
Topics: Cachexia; Gemcitabine; Humans; Muscle, Skeletal; Pancreatic Neoplasms; Prognosis; Retrospective Studies | 2023 |
A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice.
Topics: Animals; Cachexia; Carcinoma, Pancreatic Ductal; Diet, Ketogenic; Female; Gemcitabine; Male; Mice; Pancreatic Neoplasms | 2023 |
Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cachexia; Carcinoma; Cell Line, Tumor; Deoxycytidine; Eating; Gemcitabine; Humans; Mianserin; Mice; Mice, Inbred BALB C; Mice, Nude; Mirtazapine; Nutritional Status; Pancreatic Neoplasms; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |